Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Miller

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|July 17, 2007
A new approach for 'deep salvage' trials in advanced HIV infectionMichael M Lederman, Veronica Miller, Ian Weller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
Developing and evaluating comprehensive HIV infection control strategies: issues and challengesVictor DeGruttola, Davey M Smith, Susan J Little, et al.
AIDS (London, England)|April 20, 2002
To stop or not to stop: that is the question, but what is the answer?Robert S Hogg, Diane Havlir, Veronica Miller, et al.
Nature Medicine|June 12, 2025
Publisher Correction: Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
AIDS (London, England)|May 4, 2005
Antiretroviral therapies for treatment-experienced patients: current status and research challengesKimberly Struble, Jeffrey Murray, Ben Cheng, et al.
Nature Medicine|September 3, 2024
Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
Plos One|April 5, 2013
Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation setAllal Houssaini, Lambert Assoumou, Veronica Miller, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agentsHeiner Wedemeyer, Donald M Jensen, Eliot Godofsky, et al.
Journal of Virus Eradication|September 20, 2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applicationsJoseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, et al.
JAMA|August 30, 2008
Opt-out testing for human immunodeficiency virus in the United States: progress and challengesJohn G Bartlett, Bernard M Branson, Kevin Fenton, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|July 17, 2007
A new approach for 'deep salvage' trials in advanced HIV infectionMichael M Lederman, Veronica Miller, Ian Weller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
Developing and evaluating comprehensive HIV infection control strategies: issues and challengesVictor DeGruttola, Davey M Smith, Susan J Little, et al.
AIDS (London, England)|April 20, 2002
To stop or not to stop: that is the question, but what is the answer?Robert S Hogg, Diane Havlir, Veronica Miller, et al.
Nature Medicine|June 12, 2025
Publisher Correction: Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
AIDS (London, England)|May 4, 2005
Antiretroviral therapies for treatment-experienced patients: current status and research challengesKimberly Struble, Jeffrey Murray, Ben Cheng, et al.
Nature Medicine|September 3, 2024
Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.
Plos One|April 5, 2013
Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation setAllal Houssaini, Lambert Assoumou, Veronica Miller, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agentsHeiner Wedemeyer, Donald M Jensen, Eliot Godofsky, et al.
Journal of Virus Eradication|September 20, 2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applicationsJoseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, et al.
JAMA|August 30, 2008
Opt-out testing for human immunodeficiency virus in the United States: progress and challengesJohn G Bartlett, Bernard M Branson, Kevin Fenton, et al.
Pageof 11